Skip to main content

RELEVANCIA DE LA MMP-10 EN EL DESARROLLO, PROGRESION Y RUPTURA DE LA PLACA ATEROSCLEROTICA

SAF2009-12039

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2009
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre FUNDACION PARA LA INVESTIGACION MEDICA APLICADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation

  • Orbe, Josune
  • Rodríguez, José Antonio
  • Calvayrac, Olivier
  • Rodríguez-Calvo, R.
  • Rodríguez, C.
  • Roncal Mancho, Carmen
  • Martínez de Lizarrondo, Sara
  • Barrenetxe, Jaione
  • Reverter, Juan Carlos
  • Martínez-González, José
  • Páramo, José A.
Objective: thrombin is a multifunctional serine protease that promotes vascular proinflammatory responses whose effect on endothelial MMP-10 expression has not previously been evaluated. Methods and Results: thrombin induced endothelial MMP-10 mRNA and protein levels, through a protease-activated receptor-1 (PAR-1)–dependent mechanism, in a dose- and time-dependent manner. This effect was mimicked by a PAR-1 agonist peptide (TRAP-1) and antagonized by an anti–PAR-1 blocking antibody. MMP-10 induction was dependent on extracellular regulated kinase1/2 (ERK1/2) and c-jun N-terminal kinase (JNK) pathways. By serial deletion analysis, site-directed mutagenesis and electrophoretic mobility shift assay an AP-1 site in the proximal region of MMP-10 promoter was found to be critical for thrombin-induced MMP-10 transcriptional activity. Thrombin and TRAP-1 upregulated MMP-10 in murine endothelial cells in culture and in vivo in mouse aorta. This effect of thrombin was not observed in PAR-1–deficient mice. Interestingly, circulating MMP-10 levels (P<0.01) were augmented in patients with endothelial activation associated with high (disseminated intravascular coagulation) and moderate (previous acute myocardial infarction) systemic thrombin generation. Conclusion: thrombin induces MMP-10 through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Endothelial MMP-10 upregulation could be regarded as a new proinflammatory effect of thrombin whose pathological consequences in thrombin-related disorders and plaque stability deserve further investigation., This work was funded through the 'UTE project CIMA' (University of Navarra), Ministerio de Sanidad y Consumo (FIS/PI050777 and FIS/PI061480), Ministerio de Educación y Ciencia (SAF2006-07378 and SAF2009-12039), Departamento de Salud, Gobierno de Navarra (39/2004), and Red Temática de Investigación Cardiovascular RECAVA (RD06/0014/0008 and RD06/0014/0027).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

  • Martínez de Lizarrondo, Sara
  • Roncal Mancho, Carmen
  • Calvayrac, Olivier
  • Rodríguez, Cristina
  • Varo, Nerea
  • Purroy, Ana
  • Lorente, Leonardo
  • Rodríguez, José Antonio
  • Doeuvre, Loïc
  • Hervás Stubbs, Sandra
  • Anglés-Cano, Eduardo
  • Páramo, José A.
  • Martínez-González, José
  • Orbe, Josune
Objective—Thrombin induces CD40 ligand (CD40L) and matrix metalloproteinases (MMPs) under inflammatory/prothrombotic conditions. Thrombin and CD40L could modulate endothelial MMP-10 expression in vitro and in vivo. Methods and Results—Human endothelial cells were stimulated with thrombin (0.1–10 U/mL), CD40L (0.25–1 μg/mL), or their combination (thrombin/CD40L) to assess MMP-10 expression and microparticle generation. Thrombin/CD40L elicited higher MMP-10 mRNA (5-fold; P<0.001) and protein levels (4.5-fold; P<0.001) than either stimulus alone. This effect was mimicked by a protease-activated receptor-1 agonist and antagonized by hirudin, a-protease-activated receptor-1, α-CD40L, and α-CD40 antibodies. The synergistic effect was dependent on p38 mitogen-activated protein kinase and c-Jun N-terminal kinase-1 pathways. Thrombin also upregulated the expression of CD40 in endothelial cell surface increasing its availability, thereby favoring its synergistic effects with CD40L. In mice, thrombin/CD40L further increased the aortic MMP-10 expression. Septic patients with systemic inflammation and enhanced thrombin generation (n=60) exhibited increased MMP-10 and soluble CD40L levels associated with adverse clinical outcome. Endothelial and systemic activation by thrombin/CD40L and lipopolysaccharide also increased microparticles harboring MMP-10 and CD40L. Conclusion—Thrombin/CD40L elicited a strong synergistic effect on endothelial MMP-10 expression and microparticles containing MMP-10 in vitro and in vivo, which may represent a new link between inflammation/thrombosis with prognostic implications., This work was funded through the "UTE project CIMA" (Universityof Navarra) and grants SAF2009-11949, SAF2009-12039 from Ministerio de Ciencia e Innovación (MICINN), and Red Temáticade Investigación Cardiovascular RECAVA (RD06/0014/0008 andRD06/0014/0027) and FIS/PS09/00143, FIS/PI-10-01572, and I3SNS-INT-11-063 from Instituto de Salud Carlos III (Madrid, Spain). Sara Martínez de Lizarrondo and Ana Purroy were sup-ported by a fellowship from the Education Department, Gobierno de Navarra. Carmen Roncal was supported by the Ministry of Scienceand Innovation MICINN-PTQ -09-02-01941.